Impact Factor
4.45
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.20
5,931 total citations
h5-index
67
h5 depth signal
Cited share
88.5%
917 of 1,036
Total citations
5,931
Citation footprint
Metric signal
6.17
External metric anchor
Self-citation
1.3%
78 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
2,214
Portugal
375
United States
329
Finland
168
Italy
121
Citing Fields of Research
Cardiology
371
Musculoskeletal Disorders
281
Oncology
236
Immunology
235
Diabetes
212
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,284
Articles tracked across the journal lifetime
Indexed publication set
1,036
917 cited publications
Last 12 months
1,015
84.6 publications/month
Open access share
99.9%
1,014 OA publications in the last year
Leading citing country
China
2,214 citing publications
Leading citing field
Cardiology
371 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v21n1, Feb. 1989-
v21n1, Feb. 1989-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Anesthetic & Pain Medicine
Musculoskeletal Disorders
Cardiology
Immunology
Oncology
Hematology
Digestive Disorders
Issuing & Sponsoring Bodies
Contributor
Suomalainen lääkäriseura Duodecim
Broad Categories
Medicine
Musculoskeletal Disorders
Digestive Disorders
Virology
Cardiology
Hematology
Urology
Allergies
MeSH Descriptors
Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/07853890.2026.2748230
Open DOI
Association between triglyceride glucose-waist height ratio index and incident thyroid nodules: a prospective cohort study
02
DOI 10.1080/07853890.2026.2735072
Open DOI
External validation of the MOG-AR score in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease
03
04
DOI 10.1080/07853890.2026.2749299
Open DOI
Distinguishing clinical efficacy from vagal target engagement in perioperative transcutaneous auricular vagus nerve stimulation
05
DOI 10.1080/07853890.2026.2741441
Open DOI
The macroeconomic burden of four alcohol-attributable diseases in China, 1990–2023, and projections to 2030: results from GBD 2023
1. Alcohol consumption is a major contributor to disease burden, consistently ranking among the top ten risk factors in global comparative risk assessments [1–3]. In most regions, a small number of...
06
DOI 10.1080/07853890.2026.2720327
Open DOI
Metagenomic insights into the pulmonary microbiome of drug-sensitive and multidrug-resistant tuberculosis patients
07
DOI 10.1080/07853890.2026.2746866
Open DOI
Beyond HPV16/18: genotype distribution of high-risk HPV and cycle threshold values in cervical carcinogenesis spectrum
08
09
10
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 45 (2013).
Also issued online.
Formed by the union of: Annals of clinical research, and: Medical biology.
Vol. 21, no. 1 (FEB 1989)19920824 Notice not published Printed on acid-free paper